C D Owens

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Statins and other agents for vascular inflammation
    Christopher D Owens
    University of California San Francisco Medical Center, San Francisco, CA 94148, USA
    J Vasc Surg 56:1799-806. 2012
  2. ncbi An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, Calif 94148, USA
    J Vasc Surg 56:686-95. 2012
  3. ncbi Assessing drug elution technologies in the superficial femoral artery
    C D Owens
    Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Panminerva Med 53:37-49. 2011
  4. ncbi Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California, San Francisco, CA 94143 0222, USA
    J Vasc Access 11:329-34. 2010
  5. ncbi JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    J Vasc Surg 52:205-7. 2010
  6. ncbi Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California, San Francisco, Calif, USA
    J Vasc Surg 51:1152-9. 2010
  7. ncbi Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    J Vasc Surg 51:736-46. 2010
  8. ncbi In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143 0222, USA
    J Vasc Surg 50:1063-70. 2009
  9. ncbi Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage
    David K Chew
    Division of Vascular and Endovascular Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Vasc Surg 42:695-701. 2005
  10. ncbi Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial
    Andres Schanzer
    Division of Vascular and Endovascular Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Vasc Surg 46:1180-90; discussion 1190. 2007

Detail Information

Publications15

  1. ncbi Statins and other agents for vascular inflammation
    Christopher D Owens
    University of California San Francisco Medical Center, San Francisco, CA 94148, USA
    J Vasc Surg 56:1799-806. 2012
    ..The results of these trials will provide key data to help us understand the relationship between inflammation and vascular risk...
  2. ncbi An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, Calif 94148, USA
    J Vasc Surg 56:686-95. 2012
    ..This study tested the hypothesis that baseline biochemical parameters would add clinically meaningful predictive information in patients undergoing lower extremity bypass operations...
  3. ncbi Assessing drug elution technologies in the superficial femoral artery
    C D Owens
    Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Panminerva Med 53:37-49. 2011
    ..While these offer promise in improving outcomes following lower extremity intervention, caution is warranted until the safety of these new technologies can be ensured...
  4. ncbi Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California, San Francisco, CA 94143 0222, USA
    J Vasc Access 11:329-34. 2010
    ..However, factors influencing remodeling of AVF are poorly understood. We hypothesized that AVF remodeling was an endothelium-dependent process...
  5. ncbi JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    J Vasc Surg 52:205-7. 2010
    ..This article reports a patient who presented with mesenteric vein thrombosis and relatively normal peripheral blood counts. He was diagnosed with essential thrombocythemia after he tested positive for the JAK2 V617F mutation...
  6. ncbi Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California, San Francisco, Calif, USA
    J Vasc Surg 51:1152-9. 2010
    ..We hypothesized that serum biomarkers of insulin resistance and inflammation would identify a subgroup at elevated risk for graft failure, limb loss, and mortality...
  7. ncbi Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    J Vasc Surg 51:736-46. 2010
    ..This review summarizes recent translational efforts to understand the structural and functional properties of human vein grafts and places it within the context of the rich existing literature of vein graft failure...
  8. ncbi In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA 94143 0222, USA
    J Vasc Surg 50:1063-70. 2009
    ..We hypothesized that mature SVGs would exhibit endothelium-dependent, flow-mediated vasodilation (FMD). We further hypothesized that endothelium-derived nitric oxide (NO) was an important mediator...
  9. ncbi Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage
    David K Chew
    Division of Vascular and Endovascular Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Vasc Surg 42:695-701. 2005
    ..The purpose of this study was to compare the results of autogenous infrainguinal bypasses in AAs and Caucasians to determine the association of race with graft function and limb salvage...
  10. ncbi Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial
    Andres Schanzer
    Division of Vascular and Endovascular Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Vasc Surg 46:1180-90; discussion 1190. 2007
    ..We utilized data from a prospective, multicenter trial to identify technical variables that were significantly associated with early and midterm results of autogenous LEB for limb salvage...
  11. ncbi Lower extremity vein graft failure: a translational approach
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Vasc Med 13:63-74. 2008
    ..This article reviews the definition and diagnosis of vein graft failure and summarizes our current efforts to understand the mechanisms of normal and abnormal vein graft adaptation to the arterial environment...
  12. ncbi Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia
    Andres Schanzer
    Division of Vascular and Endovascular Surgery, University of Massachusetts, Worcester, MA, USA
    J Vasc Surg 47:774-781. 2008
    ..Patients with critical limb ischemia (CLI) have a large atherosclerotic burden with related high mortality. The effect of such therapies in this population is largely inferred and unproven...
  13. ncbi Risk factors for lower-extremity vein graft failure
    Thomas S Monahan
    Division of Vascular and Endovascular Surgery, University of California, San Francisco, CA 94143 0222, USA
    Semin Vasc Surg 22:216-26. 2009
    ..Therapy with statins is indicated in patients with peripheral atherosclerosis and may have beneficial effects on vein graft function, although further studies are needed in this area...
  14. ncbi Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures?
    Christopher D Owens
    Division of Vascular and Endovascular Surgery, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA
    Semin Vasc Surg 21:143-53. 2008
    ....
  15. ncbi C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta
    Karen J Ho
    Division of Vascular and Endovascular Surgery, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Am J Physiol Heart Circ Physiol 295:H1132-H1140. 2008
    ..Clinically relevant levels of CRP can stimulate SMC migration by a mechanism that may involve upregulation and activation of PDGFRbeta...